AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-137076525/orasolv-technology-rxs-cima.html" title="Facts and information about OraSolv technology.(RXs)(Cima Labs Inc.)(Brief Article)">OraSolv technology.(RXs)(Cima Labs Inc.)(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Chain Drug Review are available.
Frequently asked questions about RSS feeds
OraSolv technology.(RXs)(Cima Labs Inc.)(Brief Article)
Cima Labs Inc. says OraSolv, its orally disintegrating drug delivery technology, will be incorporated in a version of Schering-Plough Corp.'s Clarinex Reditabs. Schering recently received FDA ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- S-P to begin distribution of drug using CIMA's OraSolv.(Schering-Plough Corp.,...
- Newspaper article from: Pharma Marketletter September 5, 2005 700+ words
CIMA LABS, a division of US biotechnology firm...drug delivery technology developed by CIMA LABS. The novel formulation was approved...Clarinex Reditabs is a good example of CIMA LABS' drug delivery innovation, enhancing...
- CIMA LABS Inc.(Brief Article)
- Magazine article from: Chemical Market Reporter November 29, 1999 700+ words
CIMA LABS Inc. has received European regulatory approval for OraSolv, a fast-dissolving version of AstraZeneca's Zomig (zolmitriptan), an anti-migraine medication.
- Cephalon promotes Raj Khankari at CIMA Labs unit.(Brief article)
- Newspaper article from: Pharma Marketletter December 22, 2006 700+ words
US biopharmaceutical firm Cephalon has promoted Raj Khankari to the post of general manager at its Minneapolis-based CIMA Labs drug-delivery technology subsidiary. Dr Khankari will retain his current responsibilities as vice president of worldwide drug delivery technology.
- US FTC clears way for Cephalon's acquisition of CIMA.(Federal Trade...
- Newspaper article from: Pharma Marketletter August 16, 2004 700+ words
Almost a year since it outbid aaiPharma for CIMA Labs, Cephalon says that the US Federal Trade Commission has accepted a consent agreement that clears the way for it to complete its...
- KV Pharma prevails in CIMA/Schwarz DuraSolv patent case.(KV Pharmaceutical...
- Newspaper article from: Pharma Marketletter May 3, 2004 700+ words
...Pharmaceutical says that the US District Court for the District of Minnesota has denied a motion for a preliminary injunction filed by CIMA Labs and Schwarz Pharma, in a patent infringement action brought against KV and its subsidiary, ETHEX Corp. The Court's order...
- Cephalon and CIMA merger agreed by FTC in principle.(CIMA LABS Inc., Federal...
- Newspaper article from: Pharma Marketletter July 12, 2004 700+ words
...agreement in principle with the Federal Trade Commission, subject to final approval, for the company's proposed merger with CIMA Labs. As a result, both companies have waived their respective rights to terminate the merger agreement and intend to close this...
- Cima labs rejects bid from Cephalon.(breaking news Roundup)(Brief Article)
- Magazine article from: Chemical Market Reporter September 8, 2003 700+ words
Cima Labs Inc. has rejected Cephalon Inc.'s $384 million cash takeover bid, saying it is less favorable to stockholders than an earlier...
- CIMA LABS' OraSolv(R) Technology Used in CLARINEX(R) (desloratadine)...
- Press release article from: PR Newswire August 25, 2005 700+ words
...Aug. 25 /PRNewswire-FirstCall/ -- CIMA LABS INC., a Cephalon company , announced...drug delivery technology developed by CIMA LABS. Schering-Plough announced in July...CLARINEX Reditabs is a good example of CIMA LABS' drug delivery innovation, enhancing...
